Mayank Gandhi is the founder of Neok Bio. Neok Bio has raised $75M in total funding. Latest round: Series A. Backed by ABL Bio.
Mayank Gandhi is the CEO and Co-Founder of Neok Bio, a Palo Alto-based clinical-stage biotechnology company focused on developing bispecific antibody drug conjugates (ADCs) for solid tumor cancers. He led Neok Bio out of stealth in November 2025 with a $75 million Series A round.
Full founder directory · Investor directory · Company funding database · Fundraising library